Expanding the Scope of Noninvasive Prenatal Testing
2015; Lippincott Williams & Wilkins; Volume: 70; Issue: 8 Linguagem: Inglês
10.1097/01.ogx.0000470656.81447.e7
ISSN1533-9866
AutoresRonald J. Wapner, Joshua Babiarz, Brynn Levy, Melissa Stosic, Bernhard Zimmermann, Styrmir Sigurjonsson, Nicholas Wayham, Allison Ryan, Milena Banjevic, Phil Lacroute, Jing Hu, Megan P. Hall, Zachary Demko, Asim Siddiqui, Matthew Rabinowitz, Susan J. Gross, Matthew D. Hill, Peter Benn,
Tópico(s)Fetal and Pediatric Neurological Disorders
ResumoObstet Gynecol Surv 2015;70(8):481–482 There are noninvasive prenatal testing (NIPT) approaches using cell-free DNA in the maternal circulation to detect those women at high risk of trisomy 21, trisomy 18, trisomy 13, and sex chromosomal abnormalities. This study estimates the success of a single-nucleotide polymorphism (SNP) approach to analyzing maternal cell-free DNA in detecting 5 fetal microdeletion syndromes.
Referência(s)